Some urinary chemokines including chemokine (C-C motif) ligand 2 (CCL2) from SLE patients can be potential biomarkers for detecting preclinical renal damage and monitoring renal flares7. The gene discussed is CCL2; the disease is systemic lupus erythematosus.